NYSE:OR OR Royalties (OR) Stock Price, News & Analysis $35.60 +0.03 (+0.09%) Closing price 03:59 PM EasternExtended Trading$35.58 -0.02 (-0.07%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About OR Royalties Stock (NYSE:OR) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get OR Royalties alerts:Sign Up Key Stats Today's Range$34.93▼$35.8850-Day Range$32.89▼$42.8352-Week Range$24.76▼$48.06Volume422,038 shsAverage Volume841,536 shsMarket Capitalization$6.68 billionP/E Ratio26.57Dividend Yield0.62%Price Target$46.50Consensus RatingModerate Buy Company Overview OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes. The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets. OR Royalties seeks opportunities across a wide range of therapeutic areas—including oncology, rare diseases and specialty care—and partners with established and emerging developers. Its investment mandate covers products already on the market as well as late-stage assets nearing regulatory approval. Founded in 2021 and headquartered in London, OR Royalties has assembled a team of specialists with experience in pharmaceutical licensing, intellectual property valuation and clinical development. The portfolio spans multiple geographies, with royalties derived from sales in the United States, Europe and select international markets. This geographic diversification, coupled with exposure to different product life cycles, underpins the company’s strategy to generate steady, long-term cash flows for shareholders. Governed by an independent board and led by a management team with deep transaction and clinical expertise, OR Royalties continues to expand its holdings through disciplined deal sourcing and rigorous due diligence. The firm’s transparent royalty model and focus on revenue-generating assets position it as a dedicated vehicle for investors seeking targeted exposure to healthcare innovations without direct operational involvement in drug development.AI Generated. May Contain Errors. Read More OR Royalties Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks81st Percentile Overall ScoreOR MarketRank™: OR Royalties scored higher than 81% of companies evaluated by MarketBeat, and ranked 54th out of 181 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.0 / 5Analyst RatingModerate Buy Consensus RatingOR Royalties has received a consensus rating of Moderate Buy. The company's average rating score is 2.70, and is based on 1 strong buy rating, 5 buy ratings, 4 hold ratings, and no sell ratings.Upside PotentialOR Royalties has a consensus price target of $46.50, representing about 30.6% upside from its current price of $35.60.Amount of Analyst CoverageOR Royalties has only been the subject of 3 research reports in the past 90 days.Read more about OR Royalties' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth7.86% Earnings GrowthEarnings for OR Royalties are expected to grow by 7.86% in the coming year, from $1.40 to $1.51 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of OR Royalties is 26.57, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.68.Price to Earnings Ratio vs. SectorThe P/E ratio of OR Royalties is 26.57, which means that it is trading at a more expensive P/E ratio than the Basic Materials sector average P/E ratio of about 22.92.Price to Book Value per Share RatioOR Royalties has a P/B Ratio of 4.53. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about OR Royalties' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.26% of the float of OR Royalties has been sold short.Short Interest Ratio / Days to CoverOR Royalties has a short interest ratio ("days to cover") of 2.57, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in OR Royalties has recently increased by 31.34%, indicating that investor sentiment is decreasing significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldOR Royalties has a dividend yield of 0.61%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthOR Royalties has only been increasing its dividend for 1 years.Dividend CoverageThe dividend payout ratio of OR Royalties is 16.42%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, OR Royalties will have a dividend payout ratio of 14.57% next year. This indicates that OR Royalties will be able to sustain or increase its dividend.Read more about OR Royalties' dividend. News and Social Media2.2 / 5News Sentiment0.50 News SentimentOR Royalties has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Basic Materials companies.News Coverage This WeekMarketBeat has tracked 2 news articles for OR Royalties this week, compared to 4 articles on an average week.Search InterestOnly 12 people have searched for OR on MarketBeat in the last 30 days. This is a decrease of -48% compared to the previous 30 days.MarketBeat Follows11 people have added OR Royalties to their MarketBeat watchlist in the last 30 days. This is an increase of 267% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, OR Royalties insiders have not sold or bought any company stock.Percentage Held by Insiders0.60% of the stock of OR Royalties is held by insiders.Percentage Held by Institutions68.52% of the stock of OR Royalties is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about OR Royalties' insider trading history. Receive OR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OR Royalties and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OR Stock News HeadlinesScotiabank Brokers Lift Earnings Estimates for OR RoyaltiesMay 18, 2026 | americanbankingnews.comOR Royalties (OR) Reports Q1 Adjusted EPS BeatMay 14, 2026 | insidermonkey.comJune 12: The Biggest Buying Spree in History?Former tech executive and angel investor Jeff Brown - who picked Bitcoin, Tesla, and Nvidia before surges of up to 52,400% - says the SpaceX IPO on June 12 could trigger the biggest buying spree in market history. Brown is urging investors to get positioned before the IPO date arrives, when shares could double or more on the first day of trading.May 22 at 1:00 AM | Brownstone Research (Ad)OR Royalties Inc. (NYSE:OR) Given Consensus Rating of "Moderate Buy" by BrokeragesMay 12, 2026 | americanbankingnews.comTupac Shakur Estate Accused of Owing Producer All Eyez on Me RoyaltiesMay 12, 2026 | msn.comOR Royalties Inc.: OR Royalties Announces the Voting Results From Its Annual Meeting of ShareholdersMay 8, 2026 | finanznachrichten.deOR Royalties Announces the Voting Results From Its Annual Meeting of ShareholdersMay 7, 2026 | financialpost.comFOR Royalties Announces the Voting Results From Its Annual Meeting of ShareholdersMay 7, 2026 | globenewswire.comSee More Headlines OR Stock Analysis - Frequently Asked Questions How have OR shares performed this year? OR Royalties' stock was trading at $35.43 at the start of the year. Since then, OR stock has increased by 0.5% and is now trading at $35.6010. How were OR Royalties' earnings last quarter? OR Royalties Inc. (NYSE:OR) announced its earnings results on Wednesday, May, 6th. The basic materials company reported $0.40 earnings per share for the quarter, beating analysts' consensus estimates of $0.34 by $0.06. The basic materials company earned $102.83 million during the quarter, compared to analysts' expectations of $103.27 million. OR Royalties had a trailing twelve-month return on equity of 15.10% and a net margin of 78.09%. Read the conference call transcript. Who are OR Royalties' major shareholders? OR Royalties' top institutional shareholders include EdgePoint Investment Group Inc. (10.38%), Arrowstreet Capital Limited Partnership (1.96%), Verbena Value LP (0.69%) and Amundi (0.61%). How do I buy shares of OR Royalties? Shares of OR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of OR Royalties own? Based on aggregate information from My MarketBeat watchlists, some other companies that OR Royalties investors own include Waste Connections (WCN), American Water Works (AWK), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH), AUO (AUOTY), The RMR Group (RMR) and Triple Flag Precious Metals (TFPM). Company Calendar Record date for 4/15 Dividend3/31/2026Ex-Dividend for 4/15 Dividend3/31/2026Dividend Payable4/15/2026Last Earnings5/06/2026Today5/22/2026Record date for 7/15 Dividend6/30/2026Ex-Dividend for 7/15 Dividend6/30/2026Dividend Payable7/15/2026Next Earnings (Estimated)8/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1d) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 OR's financial health is in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorBasic Materials Industry MINING - MISC Sub-IndustryPrecious Metals Current SymbolNYSE:OR CIK1627272 Webwww.osiskogr.com Phone(514) 940-0670Fax514-940-0669Employees30Year FoundedN/APrice Target and Rating Average Price Target for OR Royalties$46.50 High Price Target$56.00 Low Price Target$38.00 Potential Upside/Downside+30.6%Consensus RatingModerate Buy Rating Score (0-4)2.70 Research Coverage10 Analysts Profitability EPS (Trailing Twelve Months)$1.34 Trailing P/E Ratio26.57 Forward P/E Ratio25.43 P/E GrowthN/ANet Income$206.09 million Net Margins78.09% Pretax Margin90.86% Return on Equity15.10% Return on Assets13.77% Debt Debt-to-Equity RatioN/A Current Ratio4.11 Quick Ratio4.11 Sales & Book Value Annual Sales$277.37 million Price / Sales24.07 Cash Flow$1.08 per share Price / Cash Flow32.88 Book Value$7.86 per share Price / Book4.53Miscellaneous Outstanding Shares187,500,000Free Float186,371,000Market Cap$6.68 billion OptionableOptionable Beta0.71 Beginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NYSE:OR) was last updated on 5/22/2026 by MarketBeat.com Staff. From Our PartnersYour computer is about to become a museum pieceVanguard holds $101 billion in three AI companies most investors have never heard of. BlackRock holds $82 bill...Eagle Publishing | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredRevealed: The Best Kept Secrets On Wall StreetTom Busby, founder of the Diversified Trading Institute, is giving away his 'Little Black Book' - a collection...DTI Trader | SponsoredOne algorithm, 17 years, nearly 2,000% total returnsA physicist in Dublin claims his AI algorithm has beaten the market for 17 consecutive years - with nearly 2,0...Porter & Company | SponsoredThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OR Royalties Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OR Royalties With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.